Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Article

  • Article
    Reduction of β-Catenin/T-Cell Transcription Factor Signaling by Aspirin and Indomethacin Is Caused by an Increased Stabilization of Phosphorylated β-Catenin
    Susanne Dihlmann, Simone Klein and Magnus von Knebel Doeberitz
    Mol Cancer Ther June 1 2003 2 (6) 509-516;

  • Article
    Characterization of the Cytotoxic Activities of Novel Analogues of the Antitumor Agent, Lavendamycin1
    Yanan Fang, Corinne M. Linardic, D. Ashley Richardson, Wen Cai, Mohammad Behforouz and Robert T. Abraham
    Mol Cancer Ther June 1 2003 2 (6) 517-526;

  • Article
    Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development1
    Paul Gibson, Jason H. Gill, Parveen A. Khan, Jill M. Seargent, Sandie W. Martin, Philip A. Batman, John Griffith, Christopher Bradley, John A. Double, Michael C. Bibby and Paul M. Loadman
    Mol Cancer Ther June 1 2003 2 (6) 527-534;

  • Article
    mRNA Expression Levels of E2F Transcription Factors Correlate with Dihydrofolate Reductase, Reduced Folate Carrier, and Thymidylate Synthase mRNA Expression in Osteosarcoma1
    Rebecca Sowers, Junya Toguchida, Jing Qin, Paul A. Meyers, John H. Healey, Andrew Huvos, Debabrata Banerjee, Joseph R. Bertino and Richard Gorlick
    Mol Cancer Ther June 1 2003 2 (6) 535-541;

  • Article
    Human Chk1 Expression Is Dispensable for Somatic Cell Death and Critical for Sustaining G2 DNA Damage Checkpoint
    Zehan Chen, Zhan Xiao, Jun Chen, Shi-Chung Ng, Thomas Sowin, Hing Sham, Saul Rosenberg, Steve Fesik and Haiying Zhang
    Mol Cancer Ther June 1 2003 2 (6) 543-548;

  • Article
    Flavopiridol Enhances the Effect of Docetaxel in Vitro and in Vivo in Human Gastric Cancer Cells1
    Monica Motwani, Carina Rizzo, Francis Sirotnak, Yuhong She and Gary K. Schwartz
    Mol Cancer Ther June 1 2003 2 (6) 549-555;

  • Article
    ZD1839, a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Shows Antimetastatic Activity Using a Hepatocellular Carcinoma Model1
    Mitsuhiro Matsuo, Hiroaki Sakurai and Ikuo Saiki
    Mol Cancer Ther June 1 2003 2 (6) 557-561;

  • Article
    Cytoreductive Effects of Farnesyl Transferase Inhibitors on Multiple Myeloma Tumor Cells1
    Yijiang Shi, Joseph Gera, Jung-hsin Hsu, Brian Van Ness and Alan Lichtenstein
    Mol Cancer Ther June 1 2003 2 (6) 563-572;

Minireview

  • Minireview
    Why Target Apoptosis in Cancer Treatment?
    Shailaja Kasibhatla and Ben Tseng
    Mol Cancer Ther June 1 2003 2 (6) 573-580;

  • Minireview
    Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging1
    Brian D. Ross, Bradford A. Moffat, Theodore S. Lawrence, Suresh K. Mukherji, Stephen S. Gebarski, Douglas J. Quint, Timothy D. Johnson, Larry Junck, Patricia L. Robertson, Karin M. Muraszko, Qian Dong, Charles R. Meyer, Peyton H. Bland, Patrick McConville, Hairong Geng, Alnawaz Rehemtulla and Thomas L. Chenevert
    Mol Cancer Ther June 1 2003 2 (6) 581-587;

  • Minireview
    Targeting Aurora-2 Kinase in Cancer1
    Steven L. Warner, David J. Bearss, Haiyong Han and Daniel D. Von Hoff
    Mol Cancer Ther June 1 2003 2 (6) 589-595;

Back to top
PreviousNext
Molecular Cancer Therapeutics: 2 (6)
June 2003
Volume 2, Issue 6
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging1

Jump to

  • Article
  • Minireview
Advertisement
  • Most Cited
  • Most Read
Loading
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • Truncated BRCA2 Contributes to PARPi Resistance
  • ERPAS to Predict Response to Endocrine Therapy
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Sialoglycan mAb for Cancer Immunotherapy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement